| Trial registration number
|
IRCT20200906048638N1 |
Full text link
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/50860
|
First author
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
mahnaz abbasi
|
Contact
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
mabasi@qums.ac.ir
|
Registration date
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-02-01
|
Recruitment status
Last imported at : April 19, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Hospitalization in corona-related wards
Confirmation of the disease by CT scan or PCR
No history of liver failure
|
Exclusion criteria
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Having non-pulmonary fungal and bacterial infections (non-pulmonary, infectious bed sores, etc.)
Lack of patient consent to participate in the study
Receive treatments other than chloroquine, azithromycin and ceftriaxone
History of receiving statins
Hypersensitivity reaction or any contraindication to the use of atorvastatin
|
Number of arms
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Qazvin University of Medical Sciences
|
Inclusion age min
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
0
|
Inclusion age max
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
90
|
primary outcome
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
crp
wbc
fever
tachikardia
heart rate
bp
sa o2
bs
plt
|
Notes
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 4
|
Arms
Last imported at : Feb. 3, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 137, "treatment_name": "Atorvastatin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|